Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules [NA]
A clinical trial comparing contrast-enhanced ultrasound (CEUS) with AMRI for detecting hepatocellular carcinoma in patients with indetermina…
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: Microbiota Modification for Immuno-oncology in Hepatocellular Carcinoma [Phase 2]
This Phase 2 clinical trial update describes microbiota modification as a strategy to enhance immuno-oncology in hepatocellular carcinoma, a…
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: 90Y Transarterial Radioembolization Versus Microwave Ablation in Small Hepatocellular Carcinoma With Hypoalbuminemia [NA]
A clinical trial comparing Y-90 transarterial radioembolization versus microwave ablation for small hepatocellular carcinoma in patients wit…
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: 29-Gene Liver Cancer Subtype and Immunotherapy Effectiveness
This clinical trial update describes a study on a 29-gene liver cancer subtype and immunotherapy in hepatocellular carcinoma, which is not y…
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: An Exploratory Study on Developing an Integrated Approach Combining Multimodal Imaging and Multi-omics Characterization of Tumor Heterogeneity for Precision Diagnosis and Treatment Optimization in Liver Cancer.
This clinical trial update describes an exploratory study at Peking Union Medical College Hospital. It aims to integrate multimodal imaging …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC [Phase 3]
This entry describes a Phase 3 trial comparing continuation of first-line radiotherapy versus early switch to second-line therapy for oligop…
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/CT in Patients With Gastrointestinal Tumors and Compared With 18F-FDG PET/CT [NA]
Completed clinical trial comparing 18F-AlF-FAPI PET/CT with 18F-FDG PET/CT in patients with gastric cancer, pancreatic cancer, and hepatocel…
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: I-FIGS Feasibility Study [NA]
Clinical trial update indicating the completion of the I-FIGS feasibility study sponsored by University Hospital Plymouth NHS Trust. The stu…
-
CLINICAL_TRIALS trial_result · 2025-07-31Clinical Trial Update: Effects of Different Anesthetic Techniques on Intraoperative and Postoperative Pain Levels and Cognitive Function in Patients Undergoing Hepatectomy for Liver Cancer [NA]
This completed clinical trial compared different anesthetic techniques to assess their impact on intraoperative and postoperative pain and c…
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 in Combination With Valganciclovir (VGCV) and Atezolizumab/Bevacizumab in Subjects With Hepatocellular Carcinoma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating safety, tolerability and efficacy of RZ-001 in combination with valganciclovir and atezolizumab/bevacizu…
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: Curative Therapy After Atezolizumab and Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma
This clinical trial update announces recruitment for a study evaluating curative therapy after initial treatment with atezolizumab and bevac…
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: CT Imaging for Guiding PA-TACE for HCC
The clinical trial evaluating CT imaging to guide PA-TACE for hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Evaluation of Efficacy and Safety of Immune Check Point Inhibitors in Hepatocellular Carcinoma Patients in Ain Shams University Hospitals
A clinical trial update from Ain Shams University Hospitals indicates enrollment of hepatocellular carcinoma patients to evaluate the effica…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Clinical Trials of the Hepatitis B Sandwich Combination Therapy for Treating Patients Infected With Hepatitis B Virus [NA]
A clinical trial entry for a Hepatitis B 'Sandwich' combination therapy for Hepatitis B infection and hepatocellular carcinoma, with the stu…
-
CLINICAL_TRIALS trial_result · 2025-07-25Clinical Trial Update: Study of Pembrolizumab and Radiotherapy in Liver Cancer [Phase 2]
Phase 2 study evaluating pembrolizumab with radiotherapy for hepatocellular carcinoma was terminated, with results posted on 2025-07-25.
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: Prophylactic Endoscopic Variceal Ligation in Patients With High-risk Esophageal Varices Receiving Atezo/Bev for HCC [Phase 2]
Phase 2 clinical trial evaluating prophylactic endoscopic variceal ligation to prevent variceal bleeding in patients with high-risk esophage…
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: Non-Interventional Registry Study to Evaluate the Effectiveness of TheraSphere® in the Treatment of Hepatocellular Carcinoma (HCC)
A completed non-interventional registry study evaluating the effectiveness of TheraSphere for hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: Pembrolizumab and Lenvatinib in Patients With Advanced HCC Who Are Refractory to Atezolizumab and Bevacizumab/ IO-based Therapy [Phase 2]
A Phase 2 trial evaluating pembrolizumab in combination with lenvatinib for advanced hepatocellular carcinoma refractory to IO-based therapy…
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: Perioperative Sintilimab Plus Bevacizumab Biosimilar and TACE-HAIC for HCC Patients With PVTT: A Phase-2 Clinical Trial [Phase 2]
Phase 2 clinical trial evaluating perioperative sintilimab plus a bevacizumab biosimilar and TACE-HAIC for hepatocellular carcinoma with PVT…
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: Role of Early API in Accurately Differentiating Hepatocellular Carcinoma From Dysplastic Nodules in Cirrhotic Patients
This clinical trial update discusses the role of an early API to differentiate hepatocellular carcinoma from dysplastic nodules in patients …
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: Acupuncture for Oxaliplatin-induced Peripheral Neuropathy in Gastro-intestinal Cancer Patients [NA]
This clinical trial is evaluating acupuncture to address oxaliplatin-induced peripheral neuropathy in patients with gastrointestinal cancers…
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer [NA]
This clinical trial update describes the HepQuant study at Montefiore Medical Center evaluating blood-based biomarkers and quantitative MR i…
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: PSMA PET for the Staging and Management of Hepatocellular Carcinoma
Clinical trial is recruiting to evaluate PSMA PET imaging for staging and management of hepatocellular carcinoma, sponsored by the VA Office…
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: Comparing the Combination of Trastuzumab and Regorafenib With Regorafenib Monotherapy for Advanced Hepatocellular Carcinoma After First-line Treatment [Phase 2]
A Phase 2 clinical trial compares the combination of trastuzumab and regorafenib versus regorafenib alone for advanced hepatocellular carcin…
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: WGc-0201 Plus Tislelizumab in HCC With High Risk of Recurrence and Metastasis After Radical Therapy [Phase 1]
A Phase 1 clinical trial update evaluating WGc-0201 in combination with tislelizumab for hepatocellular carcinoma at high risk of recurrence…